Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Assunto principal
Intervalo de ano de publicação
2.
BMJ Open ; 6(2): e009070, 2016 Feb 23.
Artigo em Inglês | MEDLINE | ID: mdl-26908513

RESUMO

OBJECTIVES: The prevalence of Huntington's disease (HD) recorded in the UK primary care records has increased twofold between 1990 and 2010. This investigation was undertaken to assess whether this might be due to an increased incidence. We have also undertaken a systematic review of published estimates of the incidence of HD. SETTING: Incident patients with a new diagnosis of HD were identified from the primary care records of the Clinical Practice Research Datalink (CPRD). The systematic review included all published estimates of the incidence of HD in defined populations. PARTICIPANTS: A total of 393 incident cases of HD were identified from the CPRD database between 1990 and 2010 from a total population of 9,282,126 persons. PRIMARY AND SECONDARY OUTCOME MEASURES: The incidence of HD per million person-years was estimated. From the systematic review, the extent of heterogeneity of published estimates of the incidence of HD was examined using the I(2) statistic. RESULTS: The data showed that the incidence of HD has remained constant between 1990 and 2010 with an overall rate of 7.2 (95% CI 6.5 to 7.9) per million person-years. The systematic review identified 14 independent estimates of incidence with substantial heterogeneity and consistently lower rates reported in studies from East Asia compared with those from Australia, North America and some--though not all--those from Europe. Differences in incidence estimates did not appear to be explained solely by differences in case ascertainment or diagnostic methods. CONCLUSIONS: The rise in the prevalence of diagnosed HD in the UK, between 1990 and 2010, cannot be attributed to an increase in incidence. Globally, estimates of the incidence of HD show evidence of substantial heterogeneity with consistently lower rates in East Asia and parts of Europe. Modifiers may play an important role in determining the vulnerability of different populations to expansions of the HD allele.


Assuntos
Doença de Huntington/epidemiologia , Adulto , Idade de Início , Registros Eletrônicos de Saúde , Humanos , Incidência , Pessoa de Meia-Idade , Prevalência , Atenção Primária à Saúde , Reino Unido/epidemiologia
3.
Neuroepidemiology ; 46(2): 144-53, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26824438

RESUMO

BACKGROUND: Reviews of the epidemiology of Huntington's disease (HD) suggest that its worldwide prevalence varies widely. This review was undertaken to confirm these observations, to assess the extent to which differences in case-ascertainment and/or diagnosis might be responsible, and to investigate whether the prevalence pattern has changed over the past 50 years. METHODS: Eighty two relevant studies were identified from Medline and Embase, previous reviews, scrutiny of references from included and excluded studies and enquiry among those interested in the field. RESULTS: The lowest rates were among the Asians and the highest among the Caucasians. The differences are not fully explained by varying approaches to case-ascertainment or diagnosis. There was evidence of an increasing prevalence of between 15 and 20% per decade in studies from Australia, North America and Western Europe. CONCLUSIONS: The prevalence of HD varies more than tenfold between different geographical regions. This variation can in part be attributed to differences in case-ascertainment and/or diagnostic criteria, but there is consistent evidence of a lower incidence in Asian populations. There is also evidence that in Australia, North America and in Western Europe (including the United Kingdom), prevalence has increased over the past 50 plus years.


Assuntos
Doença de Huntington/epidemiologia , Saúde Global , Humanos , Prevalência
4.
Bull Hist Med ; 76(3): 495-527, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12486915

RESUMO

The dominant historical narrative of Huntington's disease (Huntington's chorea) has portrayed the early American sufferers from this disorder as marginalized and vilified. This article argues, however, that afflicted families in East Hampton, New York--the site of George Huntington's mid-nineteenth-century observations--were mostly accepted and integrated within the community, some of them as members of the gentry and active participants in local governance. As descendants of early English settlers in this multiracial town, these white Presbyterian families, some of whose members were afflicted with what was locally called "St. Vitus's dance" or "that disorder," were always defined as "one of ours." While this fatal inherited neurological illness became more secret and hidden toward the end of the nineteenth century, this article suggests that it was larger cultural and social changes, rather than factors intrinsic to the disease, that led to the shift. The East Hampton story suggests the ways in which specific historical circumstances in a community may shape the-social meanings of even so severe a disease as Huntington's, and that social integration of the afflicted families may have helped mitigate the suffering of the disease.


Assuntos
Doença de Huntington/história , Atitude Frente a Saúde , História do Século XIX , Humanos , New York , Classe Social , Condições Sociais/história
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...